Antireflux surgery for patients with end-stage lung disease before and after lung transplantation

Gasper, Warren J.; Sweet, Matthew P.; Hoopes, Charles W.; Leard, Lorriana E.; Kleinhenz, Mary Ellen; Hays, Steven R.; Golden, Jeffrey A.; Patti, Marco G.

doi:10.1007/s00464-007-9494-3

Cited by 55 publications

(37 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Gasper et al showed that 35 operations (15 performed before and 20 after transplantation) were all completed laparoscopically, and 33 (94%) patients recovered uneventfully (one was readmitted for urinary tract infection and one died for causes nonrelated to the transplant). 27 The median hospital length of stay was 2 days. Similarly, Fisichella et al analyzed the perioperative morbidity and mortality of 29 consecutive lung transplant patients and 23 consecutive patients without ESLD (control group).…”

Section: Evidence That Early Antireflux Surgery In Patients With Gerdmentioning

confidence: 99%

The Intersection of GERD, Aspiration, and Lung Transplantation

Patti

Vela

Odell

et al. 2016

Journal of Laparoendoscopic & Advanced Surgical Techniques

View full text Add to dashboard Cite

Lung transplantation is a radical but life-saving treatment option for patients with end-stage lung diseases, such as idiopathic pulmonary fibrosis (IPF) and scleroderma. In light of the proposed association and controversy linking gastroesophageal reflux disease (GERD) to IPF and lung transplant outcome, the American Gastroenterological Association convened during the DDW in Washington in May 2015 a multidisciplinary group of experts in the field of GERD and lung transplantation to make considerations about the care of these patients based on available data and subsequent expert panel discussion at this symposium. The following topics were discussed: (1) pathophysiology of GERD-induced pulmonary symptoms, (2) GERD evaluation before and after lung transplantation, (3) outcome of lung transplantation for IPF and scleroderma, and (4) role of laparoscopic fundoplication before or after lung transplantation.

show abstract

Section: Evidence That Early Antireflux Surgery In Patients With Gerdmentioning

confidence: 99%

The Intersection of GERD, Aspiration, and Lung Transplantation

Patti

Vela

Odell

et al. 2016

Journal of Laparoendoscopic & Advanced Surgical Techniques

View full text Add to dashboard Cite

show abstract

“…We define a trial of azithromycin as treating continuously with azithromycin for a minimum of Anti-reflux surgery Abnormal GOR (identified by oesophageal pH probe in the majority of studies) is highly prevalent in patients with advanced lung disease and in lung transplant recipients [65,66,68,[121][122][123][124][125][126], and it has been implicated as a risk factor for BOS [65,66,68,127,128]. For this reason, committee members routinely test patients with new onset BOS for GOR.…”

Section: Remarksmentioning

confidence: 99%

An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome

et al. 2014

View full text Add to dashboard Cite

Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is associated with poor survival. The International Society for Heart and Lung Transplantation, American Thoracic Society, and European Respiratory Society convened a committee of international experts to describe and/or provide recommendations for 1) the definition of BOS, 2) the risk factors for developing BOS, 3) the diagnosis of BOS, and 4) the management and prevention of BOS.A pragmatic evidence synthesis was performed to identify all unique citations related to BOS published from 1980 through to March, 2013. The expert committee discussed the available research evidence upon which the updated definition of BOS, identified risk factors and recommendations are based. The committee followed the GRADE (Grading of Recommendation, Assessment, Development and Evaluation) approach to develop specific clinical recommendations.The term BOS should be used to describe a delayed allograft dysfunction with persistent decline in forced expiratory volume in 1 s that is not caused by other known and potentially reversible causes of posttransplant loss of lung function. The committee formulated specific recommendations about the use of systemic corticosteroids, cyclosporine, tacrolimus, azithromycin and about re-transplantation in patients with suspected and confirmed BOS.The diagnosis of BOS requires the careful exclusion of other post-transplant complications that can cause delayed lung allograft dysfunction, and several risk factors have been identified that have a significant association with the onset of BOS. Currently available therapies have not been proven to result in significant benefit in the prevention or treatment of BOS. Adequately designed and executed randomised controlled trials that properly measure and report all patient-important outcomes are needed to identify optimal therapies for established BOS and effective strategies for its prevention. Executive summaryMany lung transplant recipients develop delayed allograft dysfunction that has been traditionally referred to as bronchiolitis obliterans syndrome (BOS), which is thought to be caused by inflammation, destruction and fibrosis of small airways in the lung allograft that leads to obliterative bronchiolitis (OB). Because a definitive diagnosis of OB is difficult to make without a surgical lung biopsy, a decrease in the forced expiratory volume in 1 s (FEV1) has been used as a surrogate marker to identify patients who develop a syndrome of significant and persistent loss of lung allograft function with onset three or more months following transplantation. However, it is now recognised that numerous factors apart from OB can lead to a delayed onset, significant decline in lung function, and these causes of delayed onset graft dysfunction must be carefully excluded when a diagnosis of BOS is made. In general, BOS responds poorly to therapeutic interventions but may stabilise, and some patients may have a significant improvement in FEV1 with certain ther...

show abstract

“…Антирефлюксное хирургическое лечение. Патологичес кий ГЭР (диагностируемый в большинстве исследова ний с помощью пищеводной зондовой рН метрии) значительно распространен у больных с поздними стадиями легочных заболеваний и у реципиентов после трансплантации легких [65,66,68,[121][122][123][124][125][126].…”

Section: рекомендацияunclassified

“…Антирефлюксное хирургическое лечение (напри мер, фундопликация по Ниссену или Тупе) может быть безопасно выполнено у кандидатов на тран сплантацию с поздними стадиями хронических ле гочных заболеваний или у перенесших трансплан тацию легких с подтвержденным ГЭР [123,124,[127][128][129][132][133][134][135][136][137][138]; тем самым предотвращаются дальнейший рефлюкс и аспирация желудочного со держимого и связанные с ними осложнения.…”

Section: рекомендацияunclassified

International practical guidelines on diagnosis, prevention and treatment of bronchiolitis obliterans syndrome

Редакционная¹

2015

Pulʹmonologiâ (Mosk.)

View full text Add to dashboard Cite

РезюмеСиндром облитерирующего бронхиолита (СОБ) -серьезное осложнение трансплантации легких, при котором сокращается выживае мость больных. Международным обществом по трансплантации легких и сердца, Американским торакальным и Европейским респира торным обществами созданы Международный комитет экспертов для разработки клинических рекомендаций по ведению пациентов с СОБ. В этих Рекомендациях дано определение СОБ, описаны факторы риска, диагностика, ведение больных и профилактика СОБ. Для разработки Рекомендаций собрана доказательная информация по СОБ с 1980 г. до марта 2013 г. Комитетом экспертов обсуждались доступные научные доказательства. Оценка Рекомендаций проводилась по системе GRADE. Термин СОБ относится к поздней дис функции трансплантата с неуклонным снижением объема форсированного выдоха за 1 ю секунду, необъяснимое другими причинами. В данных Рекомендациях обсуждаются вопросы использования системных глюкокортикостероидов, циклоспорина, такролимуса, азит ромицина и ретрансплантации у больных с предполагаемым и подтвержденным СОБ. В случае диагноза СОБ требуется тщательное исключение других посттрансплантационных осложнений с поздней дисфункцией трансплантата. Выявлено несколько факторов рис ка, тесно связанных с развитием СОБ. В настоящее время отсутствует лечение, при помощи которого можно бы предотвратить или существенно повлиять на СОБ. Для поиска оптимальных методов лечения и эффективных мер профилактики необходимы хорошо спланированные рандомизированные контролируемые исследования, в которых прослеживались бы все значимые для пациента пока затели. Ключевые слова: синдром облитерирующего бронхиолита, трансплантация легких, поздняя дисфункция трансплантата, клинические рекомендации, факторы риска, лечение. DOI: 10.18093/0869 0189 2015 25 4 403 424 International practical guidelines on diagnosis, prevention and treatment of bronchiolitis obliterans syndrome SummaryBronchiolitis obliterans syndrome (BOS) is a serious complication of lung transplantation that decreases the patients' survival. The International Society for Heart and Lung Transplantation, American Thoracic Society, and European Respiratory Society developed the current recommenda tions for better definition of BOS, describing risk factors for developing BOS, diagnosis, management and prevention of BOS. The recommenda tions were based on the evidenced data published from 1980 through to March, 2013 and were evaluated according to the GRADE system. The committee discussed the use of systemic corticosteroids, cyclosporine, tacrolimus, azithromycin and re transplantation in patients with BOS. The diagnosis of BOS should be made after exclusion of other post transplant complications that can cause persistent lung function decline. Currently, there is no therapy able to improve significantly or to prevent BOS development. Further randomised controlled trials are needed to search optimal therapies and preventive measures for BOS.

show abstract

Antireflux surgery for patients with end-stage lung disease before and after lung transplantation

Cited by 55 publications

References 16 publications

The Intersection of GERD, Aspiration, and Lung Transplantation

The Intersection of GERD, Aspiration, and Lung Transplantation

An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome

International practical guidelines on diagnosis, prevention and treatment of bronchiolitis obliterans syndrome

Contact Info

Product

Resources

About